Trial NCT01440595

View at ClinicalTrials.gov 
Org. Study IDs: 5172-012
Secondary IDs: 2011-003299-36

Last trial update was posted on 2018-09-14

MeSH Interventions

Grazoprevir Peginterferon alfa-2b Ribavirin

MeSH Conditions

Hepatitis Hepatitis A Hepatitis C Hepatitis C, Chronic

Other Conditions


Stopping Reasons

Preliminary results of MK-5172 PN003 (NCT01353911) suggested a possible dose relationship to elevated transaminase levels in treatment with grazoprevir.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID